JSPR
Price
$5.49
Change
-$0.20 (-3.51%)
Updated
Jun 27 closing price
Capitalization
82.47M
UBX
Price
$0.77
Change
-$0.02 (-2.53%)
Updated
Jun 27 closing price
Capitalization
13.28M
Interact to see
Advertisement

JSPR vs UBX

Header iconJSPR vs UBX Comparison
Open Charts JSPR vs UBXBanner chart's image
Jasper Therapeutics
Price$5.49
Change-$0.20 (-3.51%)
Volume$1.98M
Capitalization82.47M
Unity Biotechnology
Price$0.77
Change-$0.02 (-2.53%)
Volume$54.34K
Capitalization13.28M
JSPR vs UBX Comparison Chart in %
Loading...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JSPR vs. UBX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSPR is a Hold and UBX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (JSPR: $5.49 vs. UBX: $0.77)
Brand notoriety: JSPR and UBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JSPR: 784% vs. UBX: 17%
Market capitalization -- JSPR: $82.47M vs. UBX: $13.28M
JSPR [@Biotechnology] is valued at $82.47M. UBX’s [@Biotechnology] market capitalization is $13.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JSPR’s FA Score shows that 2 FA rating(s) are green whileUBX’s FA Score has 0 green FA rating(s).

  • JSPR’s FA Score: 2 green, 3 red.
  • UBX’s FA Score: 0 green, 5 red.
According to our system of comparison, JSPR is a better buy in the long-term than UBX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JSPR’s TA Score shows that 3 TA indicator(s) are bullish while UBX’s TA Score has 4 bullish TA indicator(s).

  • JSPR’s TA Score: 3 bullish, 5 bearish.
  • UBX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, UBX is a better buy in the short-term than JSPR.

Price Growth

JSPR (@Biotechnology) experienced а +6.60% price change this week, while UBX (@Biotechnology) price change was -5.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JSPR($82.5M) has a higher market cap than UBX($13.3M). UBX YTD gains are higher at: -20.995 vs. JSPR (-74.322). UBX has higher annual earnings (EBITDA): -24.46M vs. JSPR (-81.61M). JSPR has more cash in the bank: 48.8M vs. UBX (16.9M). JSPR has less debt than UBX: JSPR (2.59M) vs UBX (18.7M). JSPR (0) and UBX (0) have equivalent revenues.
JSPRUBXJSPR / UBX
Capitalization82.5M13.3M620%
EBITDA-81.61M-24.46M334%
Gain YTD-74.322-20.995354%
P/E RatioN/AN/A-
Revenue00-
Total Cash48.8M16.9M289%
Total Debt2.59M18.7M14%
FUNDAMENTALS RATINGS
UBX: Fundamental Ratings
UBX
OUTLOOK RATING
1..100
39
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JSPRUBX
RSI
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
65%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
63%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
66%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 14 days ago
72%
Bullish Trend 10 days ago
76%
Declines
ODDS (%)
Bearish Trend 10 days ago
83%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TURB2.370.05
+2.35%
Turbo Energy SA
CPAY327.041.00
+0.31%
Corpay
CCOI48.200.04
+0.08%
Cogent Communications Holdings
AMRK21.16-0.75
-3.42%
A-Mark Precious Metals
LOOP1.34-0.05
-3.60%
Loop Industries

JSPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, JSPR has been loosely correlated with AVXL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if JSPR jumps, then AVXL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JSPR
1D Price
Change %
JSPR100%
-3.51%
AVXL - JSPR
38%
Loosely correlated
-0.94%
ABOS - JSPR
38%
Loosely correlated
-7.44%
MNMD - JSPR
38%
Loosely correlated
-2.82%
DSGN - JSPR
36%
Loosely correlated
-6.54%
ABCL - JSPR
35%
Loosely correlated
-3.48%
More

UBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, UBX has been loosely correlated with LRMR. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if UBX jumps, then LRMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UBX
1D Price
Change %
UBX100%
-1.73%
LRMR - UBX
35%
Loosely correlated
N/A
HOFBF - UBX
34%
Loosely correlated
N/A
ABCL - UBX
33%
Loosely correlated
-3.48%
MNMD - UBX
33%
Poorly correlated
-2.82%
JSPR - UBX
33%
Poorly correlated
-3.51%
More